Basking Biosciences Inc Employee Directory
Biotechnology ResearchOhio, United States11-50 Employees
Basking Biosciences is a clinical-stage biopharmaceutical company redefining how potentially life-threatening blood clots are treated. Its novel, investigational therapies are designed to significantly improve safety and efficacy, broadening access to many more patients. Its lead program, BB-031, is the first rapid-onset, short-acting thrombolytic therapy with a reversal agent, currently in development for the treatment of acute ischemic stroke (AIS). By inhibiting von Willebrand Factor (vWF), a key driver in clot formation, BB-031 aims to deliver targeted, potent thrombolytic activity that could enable more patients to receive timely, life-saving treatment after stroke.